EU Clinches Vaccine Deal With Pfizer as Doses Surge in the Bloc

The EU expects to receive almost 29 million vaccines this week
The EU concluded talks with Pfizer over 1.8 billion more doses

Vials of Covid-19 vaccine, produced by Pfizer Inc. and BioNTech SE, in cold storage at a Covid-19 vaccination center in Paris, France. — Vials of Covid-19 vaccine, produced by Pfizer Inc. and BioNTech SE, in cold storage at a Covid-19 vaccination center in Paris, France.
Photographer: Nathan Laine/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Alberto Nardelli and Nikos Chrysoloras

April 29, 2021 at 9:57 AM UTC

This article is for subscribers only.

The European Union said it concluded negotiations with Pfizer Inc. and BioNTech SE to deliver a massive supply of Covid vaccines to the bloc, adding to a surge of doses that’s clearing the way for economies to reopen and travel to begin again.

The European Commission informed member states on Wednesday about the deal, which is expected to cover 1.8 billion additional Covid doses through 2023, according to a diplomatic note seen by Bloomberg.